Feasibility and efficacy of endoscopic ultrasound-guided iodine-125 seed implantation in inoperable ampullary carcinoma: initial clinical experience

Tingting Cui; Lianqiang Han; Nianjun Xiao; Fang Liu; Wen Li

doi:10.5114/jcb.2022.116121

eISSN: 2081-2841
ISSN: 1689-832X

Journal of Contemporary Brachytherapy

Current Issue Archive Supplements Articles in Press Journal Information Aims and Scope Editorial Office Editorial Board Register as Author Register as Reviewer Instructions for Authors Abstracting and indexing Subscription Advertising Information Links

Editorial System

Submit your Manuscript

3/2022
vol. 14

Send email

Copy url:

abstract:

Original paper

Feasibility and efficacy of endoscopic ultrasound-guided iodine-125 seed implantation in inoperable ampullary carcinoma: initial clinical experience

Tingting Cui

^{1, 2}

,

Lianqiang Han

^{2, 3}

,

Nianjun Xiao

^{1, 4}

,

Fang Liu

²

,

Wen Li

²

Department of Gastroenterology and Hepatology, Medical School of Chinese PLA, Beijing, China
Department of Gastroenterology and Hepatology, the First Medical Center, Chinese PLA General Hospital, Beijing, China
School of Medicine, Nankai University, Tianjin, China
Department of Gastroenterology, Air Force Medical Center, Beijing, China

J Contemp Brachytherapy 2022; 14, 3: 233-240

DOI: https://doi.org/10.5114/jcb.2022.116121

Online publish date: 2022/05/10

View full text Get citation

Purpose
The objectives of the present study were to evaluate the feasibility, safety, and efficacy of endoscopic ultrasound (EUS)-guided iodine-125 (125I) seed implantation in ampullary carcinoma (AC).

Material and methods
From January 2011 to June 2020, 13 patients were selected for this retrospective study. Thirteen tumors (27.46 ±12.07 mm) were treated with EUS-guided 125I seed implantation in 29 sessions. We evaluated the therapeutic efficacy, adverse effects, and overall survival (OS) time.

Results
Complete response (CR) was observed in one tumor in 6 months. Partial response (PR) was detected in two target tumors in 3 months, seven in 6 months, seven in 9 months, and six in 12 months. Good periods of survival were observed. The median OS was 35 months, 95% confidence interval (95% CI) was 8.97 to 61.03 months. The 1-, 2-, and 5-year OS rates were 100%, 67.5%, and 11.3%, respectively. There were no procedure-related deaths or serious adverse events. Transient abdominal pain (5 cases, 17.2%), abdominal distension and loss of appetite (3 cases, 10.3%), and seed migration (1 case, 3.4%) were observed, respectively.

Conclusions
In selected patients with inoperable AC, EUS-guided 125I seed implantation is feasible and safe with favorable local control efficacy and OS.

keywords:

Feasibility and efficacy of endoscopic ultrasound-guided iodine-125 seed implantation in inoperable ampullary carcinoma: initial clinical experience

Tingting Cui 1, 2 , Lianqiang Han 2, 3 , Nianjun Xiao 1, 4 , Fang Liu 2 , Wen Li 2

endoscopic ultrasound, adenocarcinoma, ampullary, brachytherapy

Tingting Cui

^{1, 2}

,

Lianqiang Han

^{2, 3}

,

Nianjun Xiao

^{1, 4}

,

Fang Liu

²

,

Wen Li

²